66967-92-8

Basic information

• Product Name: {3-[(dimethylcarbamoyl)oxy]pyridin-2-yl}-N,N,N-trimethylmethanaminium bromide
• CAS NO: 66967-92-8
• Molecular Formula: C₁₂H₂₀BrN₃O₂
• Molecular Weight: 318.2101
• Mol File: 66967-92-8.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: {3-[(dimethylcarbamoyl)oxy]pyridin-2-yl}-N,N,N-trimethylmethanaminium bromide(CAS DataBase Reference)
• NIST Chemistry Reference: {3-[(dimethylcarbamoyl)oxy]pyridin-2-yl}-N,N,N-trimethylmethanaminium bromide(66967-92-8)
• EPA Substance Registry System: {3-[(dimethylcarbamoyl)oxy]pyridin-2-yl}-N,N,N-trimethylmethanaminium bromide(66967-92-8)

Safety Data

• Hazardous Substances Data: 66967-92-8(Hazardous Substances Data)

Usage

Description

3-[(dimethylcarbamoyl)oxy]pyridin-2-yl-N,N,N-trimethylmethanaminium bromide, also known as Nicotinamide N-methyltransferase inhibitor, is a synthetic compound that serves as an inhibitor for the enzyme nicotinamide N-methyltransferase. This enzyme plays a crucial role in the metabolism of nicotinamide, a vital precursor in the synthesis of NAD+ (nicotinamide adenine dinucleotide), a coenzyme that participates in various cellular processes. By inhibiting the activity of this enzyme, 3-[(dimethylcarbamoyl)oxy]pyridin-2-yl-N,N,N-trimethylmethanaminium bromide has potential applications in the treatment of certain diseases, including cancer and metabolic disorders. Studies have shown its therapeutic potential as a novel target for drug development, although further research is necessary to fully comprehend its mechanisms and potential clinical applications.

Uses

Used in Pharmaceutical Industry:
3-[(dimethylcarbamoyl)oxy]pyridin-2-yl-N,N,N-trimethylmethanaminium bromide is used as a therapeutic agent for the treatment of certain diseases, such as cancer and metabolic disorders, due to its ability to inhibit the enzyme nicotinamide N-methyltransferase, which is involved in the synthesis of NAD+.
Used in Drug Development:
In the field of drug development, 3-[(dimethylcarbamoyl)oxy]pyridin-2-yl-N,N,N-trimethylmethanaminium bromide is utilized as a novel target for the creation of new drugs that can potentially treat a range of diseases by modulating the activity of the enzyme nicotinamide N-methyltransferase.
Used in Research and Development:
3-[(dimethylcarbamoyl)oxy]pyridin-2-yl-N,N,N-trimethylmethanaminium bromide is employed as a research tool in the study of the enzyme nicotinamide N-methyltransferase and its role in cellular processes, as well as in the investigation of the compound's potential therapeutic effects and mechanisms of action.